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Background: Resistance to traditional insecticides represents a threat to the control of disease vectors. The insect
growth regulators (IGR) are a potential alternative to control mosquitoes, including resistant populations. The chitin
synthesis inhibitors (CSI) are IGRs, which interfere with the insect molting process and represent one major class of
compounds against Aedes aegypti populations resistant to the larvicide organophosphate temephos. In the present
study, we evaluated the efficacy of the CSI triflumuron on Culex quinquefasciatus, Aedes albopictus and against
several Ae. aegypti field populations.
Methods: The efficacy of triflumuron, against Cx. quinquefasciatus and Ae. albopictus was evaluated with laboratory
strains through dose–response assays. Additionaly, this CSI was tested against seven Ae. aegypti field populations
exhibiting distinct resistance levels to both temephos and the pyrethroid deltamethrin. Aedes aegypti populations
were exposed to both a dose that inhibits 99% of the adult emergence of mosquitoes from the susceptible reference
strain, Rockefeller, (EI99 = 3.95 μg/L) and the diagnostic dose (DD), corresponding to twice the EI99.
Results: Our results indicate that triflumuron was effective in emergence inhibition (EI) of Cx. quinquefasciatus
(EI50= 5.28 μg/L; EI90= 12.47 μg/L) and Ae. albopictus (EI50= 1.59 μg/L; EI90= 2.63 μg/L). Triflumuron was also effective
against seven Ae. aegypti Brazilian populations resistant to both temephos and deltamethrin. Exposure of all the
Ae. aegypti populations to the triflumuron EI99 of the susceptible reference strain, Rockefeller, resulted in complete
inhibition of adult emergence, suggesting no cross-resistance among traditional insecticides and this CSI.
However, a positive correlation between temephos resistance and tolerance to triflumuron was observed.
Conclusion: The results suggest that triflumuron represents a potential tool for the control of disease vectors in
public health. Nevertheless, they point to the need of constant monitoring of the susceptibility status of vector
populations to CSIs.
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Insecticide resistanceBackground
Aedes aegypti, Aedes albopictus and Culex quinquefasciatus
mosquitoes are widely distributed across the globe, mainly
in tropical and subtropical regions [1]. The presence
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reproduction in any medium, provided the orbecause they are involved in transmission of diseases,
such as dengue, yellow fever and lymphatic filariasis [2-4].
In Latin America, the presence of these mosquitoes
involves an additional risk, as they are also potential
vectors of chikungunya and the West Nile virus, two
arboviruses not yet reaching this continent [5-7].
Currently, organophosphates (OP) and pyrethroids (PY)
still play an important role in vector control. However,
their effectiveness has been hampered due to resistance
[8-11]. In this sense, the use of new products is a cruciall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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strategies [12,13].
Compared to conventional insecticides, like OP and
PY, insect growth regulators (IGRs) have distinct mech-
anisms of action and are more selective. Additionally,
IGRs are safe for most non-target organisms, and are
therefore considered as a promising alternative for in-
sect control [12,14]. Chitin synthesis inhibitors (CSI)
are IGRs that interfere with the insect moult. CSIs be-
long to the benzoyl urea family, a chemical group that
has been extensively studied since its discovery in the
1970s [14]. CSI exposure results in deformities of the
larval cuticle, which often become unable to survive to
the next moult [15-17].
Although the CSI mechanism of action is unclear,
there are several reports of its effectiveness against in-
sects, especially in larvae [17-21]. However, since chitin
is a molecule present in all life stages of insects, it is
likely that a series of mosquito structures are affected as
well. Wilson and Cryan, for example, verified that lufenuron
affects Drosophila melanogaster eggs [22]. Moreover,
it has been shown that exposure of larvae to partially
lethal doses of CSIs causes a series of disabilities in both
viability and reproduction of resulting adults [23-27].
The use of CSIs has been intensified against resistant
mosquito populations, given their mechanism of action is
distinct from neurotoxic insecticides traditionally employed.
Thus, evaluation of the efficacy of CSI on Ae. aegypti field
populations is essential for rational vector control measures.
In addition, the study of CSI effects on other mosquitoes
could be important for the development of integrated
control strategies.
Under laboratory conditions, triflumuron is effective
against Ae. aegypti [20]. When larvae are exposed to a
sublethal dose, the viability of resulting adults is affected
[26]. In the present study, we evaluated the effect of this
CSI in several Ae. aegypti Brazilian populations with
distinct resistance levels to temephos and deltamethrin.
Additionally, laboratory strains of Cx. quinquefasciatus
and Ae. albopictus, two other mosquitoes of medical
importance, were exposed to several triflumuron doses,




Aedes aegypti populations were chosen according to their
geographical location (Figure 1) and resistance levels to
both temephos (OP) and deltamethrin (PY). Mosquitoes
from the Rockefeller strain, an insecticide-susceptible ref-
erence lineage [28], were used as the experimental control.
Aedes albopictus and Cx. quinquefasciatus strains were
collected in Rio de Janeiro city and maintained in the
laboratory for five and thirteen years, respectively.However, these laboratory strains are not considered as
insecticide susceptible reference strains.
In all cases, groups of 1,000 first instar larvae were
reared in plastic basins (33 × 24 × 8 cm) containing 1 L
of dechlorinated water and 1 g of cat food (FriskiesW,
Purina, Camaquã/RS). Larvae from all species and popu-
lations were kept in a biological oxygen demand incuba-
tor (BOD) at 25 ± 1°C until the third instar, when assays
were performed.
Insecticides
The CSI trifumuron Starycide SC 0.48W (triflumuron
48%) was provided by BayerCropscience. PESTANALW
analytical standard of temephos (97.5%) and deltamethrin
(99.7%) were purchased from Sigma-Aldrich.
Triflumuron bioassays
Dose–response bioassays were performed to evaluate
triflumuron efficacy against Ae. albopictus and Cx.
quinquefasciatus. Groups of 10 third instar larvae were
exposed to 150 mL of triflumuron solution in trans-
parent plastic cups. The concentrations ranged from
0.25 μg/L to 4.5 μg/L for Ae. albopictus and from
2.5 μg/L to 50 μg/L for Cx. quinquefasciatus. One milli-
liter of a 2.5% (w/v) solution of ground cat food (FriskiesW,
Purina, Camaquã/RS) was supplied once. Eight replicates
were used for each concentration. Daily, mortality at
each stage was checked and the resulting adults were
collected [20,26].
Aedes aegypti populations were submitted to two
triflumuron doses: one corresponding to the dose
inhibiting Rockefeller adult emergence at 99% (EI99)
and the diagnostic dose (DD), defined as twice the EI99
[29]. For both concentrations, eight replicates were
utilized under the same conditions, as described above.
The EI99 and DD doses were 3.95 μg/L and 7.9 μg/L, re-
spectively [20]. For all populations, triflumuron assays were
performed on the F2 generation; except Maceió (AL),
with F3.
In contrast to the neurotoxic insecticides, triflumuron
bioassays were monitored for several days, until all in-
sects either died or reached adulthood. Adult emergence
inhibition (EI) data were registered as soon as all control
group specimens emerged [20]. The results were used to
calculate the EI50 and EI90 values that correspond to the
triflumuron doses necessary to inhibit adult develop-
ment of 50 and 90% of the specimens, respectively.
Temephos and deltamethrin bioassays to determine the
resistance level of the Ae. aegypti populations
Temephos resistance was evaluated through bioassays [29].
Groups of 20 third instar larvae were exposed to ten
temephos concentrations in plastic cups with 100 ml of
solution. Four replicates were used for each temephos dose.
Figure 1 Geographic location of the Ae. aegypti populations adopted in triflumuron assays.
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as described by Da-Cunha et al. [9]. Each assay consisted
of three 250 mL Wheaton bottles impregnated with the
DD of this PY (5 μg/bottle), defined in this assay as the
minimal amount of insecticide that kills all the speci-
mens of a susceptible reference strain. One control bot-
tle was impregnated only with acetone as solvent. Each
bottle received 20 females, non-blood fed, one to three
days old. Knock down (KD) was monitored at 15 min
intervals up to 2 hours. Mosquitoes were then trans-
ferred to cages free of insecticide and mortality was reg-
istered again 24 hours later.
Statistical analysis
All the assays described here were repeated three times.
The trifumuron effective doses EI50 and EI90 were calcu-
lated by probit analysis [30].
Since in Brazil the RR95 values are used to guide rec-
ommendations of temephos application in the field, the
resistance ratios (RR) of Ae. aegypti field populations to
temephos were calculated with values of the lethal con-
centrations that kill 95% of larvae (LC95). RRs were
obtained by dividing the LC of the field populations by
the equivalent LC from the Rockefeller strain.
ANOVA was adopted to compare the rate of pupae
mortality among Ae. aegypti populations. Pearson’s cor-
relation was employed to investigate the relationship
between pupae mortality after exposure to triflumuron
and resistance levels to temephos of Ae. aegypti field
populations. The Graph-Pad Prism software version
5.0 for Windows was used to perform these analyzes
(GraphPad Software, San Diego California USA, www.
graphpad.com).Results
Effect of triflumuron on Ae. albopictus
The effective EI50 and EI90 doses inhibiting emergence were
1.59 μg/L and 2.63 μg/L, respectively (Table 1). No adult
emergence occurred at concentrations above 3.0 μg/L.
Mortality in the control group, not exposed to the CSI,
remained below 4%. Figure 2 shows Ae. albopictus mor-
tality at each stage and indicates the direct relationship
between triflumuron concentration and the precocity
of its effects. There were higher larval mortality rates
at the highest triflumuron doses. Mortality at the pupal
and adult stages was evident mainly in intermediate
concentrations, respectively between 1.25 μg/L and
3.5 μg/L and at lower doses, up to 3.0 μg/L.
Effect of triflumuron on Cx. quinquefasciatus
The EI50 and EI90 values for this species were 5.28 μg/L
and 12.47 μg/L, respectively (Table 1). No viable adults
were recovered above 15.0 μg/L. Mortality in the con-
trol group was 4.7%. Stage-specific mortality of Cx.
quinquefasciatus exhibited the same pattern observed
for Ae. albopictus (Figure 3). Larval mortality was dir-
ectly proportional to the doses employed, while pupal
and adult mortality rates were higher at intermediate
and lower doses, respectively.
Effect of triflumuron, deltamethrin and temephos on
Ae. aegypti field populations
Effective doses of triflumuron for Ae. aegypti remained
between 1.5-1.8 fold below the equivalent ones for Ae.
albopictus (Table 1). Triflumuron was effective against
all field populations evaluated, regardeless of their resist-
ance levels to deltamethrin and temephos (Table 2). In



















Figure 3 Stage-specific mortality of Cx. quinquefasciatus
exposed to different triflumuron concentrations.
Table 1 Effective doses (ug/L) of triflumuron against the
different mosquitoe species evaluated
Ae. aegypti* Ae. albopictus Cx. quinquefasciatus
EI50 0.86 (0.80-0.93) 1.59 (1.54-1.63) 5.28 (4.15-6.72)
EI90 1.80 (1.51-2.17) 2.63 (2.42-2.64) 12.47 (8.85-17.60)
EI99 3.95 (2.46-4.49) 3.95 (3.35-4.68) 25.11 (12.9-48.86)
Values between parentheses represent the confidence intervals 95% (95% CI).
*Martins et al. [20].
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the control groups remained below 3%. Approximately
ten days after the initiation of the experiments, all larvae
from the control groups, reared without triflumuron,
had already reached adulthood. In the same period, up
to 86.3% and 99.2% of specimens were dead in the
experimental groups exposed to the triflumuron EI99
and DD, respectively. Both concentrations completely
blocked adult emergence in all populations evaluated
(Table 2). However, a small proportion of larvae remained
alive for a long period of time. When populations were
exposed to EI99, total mortality resulted between 18
(Rockefeller strain) and 24 days (Montes Claros/MG)
after the beginning of the bioassays. For DD, total mor-
tality ranged between 17 and 52 days, in Maceió and
Montes Claros samples, respectively.
Figure 4 shows the stage-specific mortality of several
Ae. aegypti populations exposed to triflumuron EI99. In
this figure, populations are arranged according to their
temephos resistance levels, in growth order. The rate of
dead pupae in the municipality of Aracaju/SE, the popu-
lation exhibiting the highest temephos resistance level,
was significantly higher than that in other populations
(ANOVA; p < 0.05). Significant differences were also
evidenced in the rate of pupal mortality of Maceió/AL
and Montes Claros/MG when compared to the Rocke-
feller strain (ANOVA; p < 0.05). Except for Cuiabá/MT
and Dourados North/MS, all these populations exhibited
high temephos resistance levels, as shown in Table 2



















Figure 2 Stage-specific mortality of Ae. albopictus exposed to
different triflumuron concentrations.In general, when field populations were exposed to
triflumuron EI99, a positive correlation between temephos
resistance levels and the rate of pupal mortality was
found (r2 = 0,7293; p < 0,05). The same correlation was
not observed when populations were exposed to DD. In
contrast to temephos resistance evaluation, deltamethrin
bioassays were limited to exposure to a single dose of
the pyrethroid. According to this bioassay, all Ae. aegypti
populations were classified as resistant to deltamethrin
(Table 2). Nevertheless, there was never a correlation
between deltamethrin mortality rates and pupae mortal-
ity in Ae. aegypti populations exposed to EI99 and DD of
triflumuron noted.
Discussion
Insecticide resistance is a growing problem that hampers
mosquito control in different regions around the world.
Nowadays, resistance to the main neurotoxic insecticide
classes has spread among several populations of insect
disease vectors. Therefore, biological control methods
and the use of chemicals with distinct mechanisms of
action have been increasingly employed. The utilization
of chitin synthesis inhibitors, for example, represents
one major current strategy for mosquito chemical con-
trol. For this reason, evaluation of the efficacy of such
compounds on mosquito field populations is essential.
This work deals with the CSI triflumuron efficacy against
Ae. aegypti field populations, as well as laboratory colonies
of Ae. albopictus and Cx. quinquefasciatus.
Our results indicate that triflumuron, under laboratory
conditions, is effective against the three mosquito species
evaluated. As expected, this compound induced adult emer-
gence inhibition of Ae. albopictus and Cx. quinquefasciatus
in a dose-dependent way. Previous results of our group
have proven that this compound acts in a similar way on
Ae. aegypti [20]. Novaluron, another CSI, has the same ef-
fect on this mosquito [17]. Moreover, other IGRs, such as
methoprene (juvenile hormone mimic) and halofenozide
(ecdysone agonist), exhibited similar results [33,34].
Table 2 Temephos and deltamethrin resistance levels in Ae. aegypti field populations
Locality/Strain Temephos Deltamethrin Triflumuron,% mort
RR95
a % mort DDb EI99 DD
c
Rockefeller 1.0 100.0 100.0 100.0
Aracaju/SE 19.3 88.1 100.0 100.0
Maceió/AL 10.3 62.9 100.0 100.0
Belo Horizonte/MG 5.4 74.5 100.0 100.0
Montes Claros/MG 13.6 62.7 100.0 100.0
Dourados (North)/MS 4.3 87.9 100.0 100.0
Dourados-(South)/MS 7.1 61.9 100.0 100.0
Cuiabá/MT 4.0 89.2 100.0 100.0
aIn Brazil, localities with Ae. aegypti populations exhibiting temephos RR95 higher than 3.0 are subjected to insecticide substitution [31]. Note that RR is based on
dose–response assays, distinct from the remaining qualitative tests depicted in this table.
bthe diagnostic dose (DD) of deltamethrin used was 5 μg/bottle [9]. According to this assay, mortality below 80% indicates resistance [32].
cthe diagnostic dose of triflumuron employed, equivalent to twice the EI99, was7.9 μg/L.
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caused more pronounced mortality of mosquito larvae,
relative to pupae and adults [17,18,35]. These results
corroborate the data presented here, performed with
triflumuron, and confirm the direct relationship between
CSI concentrations and the precocity of their effects.
Triflumuron EI50 and EI90 against Cx. quinquefasciatus
(Table 1) were 3.3 and 4.7 times higher than the corre-
sponding values in Ae. albopictus. In this latter species,
in turn, triflumuron effective doses were around 1.5 -
1.8 times higher than in Ae. aegypti (EI50 and EI90 of
0.86 μg/L and 1.8 μg/L, respectively) [20]. The triflumuron
doses recommended by the manufacturer for Aedes and
Culex control are around 0.12 g/L and 0.24 g/L, respect-
ively [36], values much higher than the effective concen-
trations for these culicids.
Although there are some reports related to field simu-
lated assays, to our knowledge this is the first evaluation
of the triflumuron effect on Ae. albopictus under labora-
tory conditions. With respect to Cx. quinquefasciatus, our
results slightly differ from other reports, which declared
EI50 and EI90 values of 2.0 and 7.0 μg/L, respectively



















Figure 4 Stage-specific mortality induced by triflumuron of seven Ae.
organized according to the resistance level to temephos. Distinct letters ab
rates (p < 0.05).among different laboratories are very common and are
derived, in part, from the use of distinct protocols, as
already discussed by Braga et al. [34]. Additionally, vari-
ations in effective doses among different CSIs for a
given species, or among different insect species for a
given CSI, have also been reported. Diflubenzuron, the
first chitin synthesis inhibitor commercially available,
has been used in the control of various insect species,
especially in agriculture [14]. Concentrations of 0.5 μg/L
of this compound resulted in 50% of Cx. quinquefasciatus
larval mortality [37]. Su et al. found for novaluron,
another promising CSI, EI50 and EI90 of respectively
0.16 and 0.60 μg/L for Cx. quinquefasciatus [35]. Ali et al.
studied the effect of diflubenzuron in Ae. albopictus and
encoutered an EI50 of 0.45 μg/L for this species, the EI90
being 0.84 μg/L [39]. Hexaflumuron, another CSI, also
proved very effective against Ae. albopictus, with the EI50
of 0.2 μg/L [40].
Although effective doses of triflumuron are higher
when compared to other IGRs, Mian and Mulla empha-
sized the efficient activity of this CSI on mosquitoes,
which is confirmed by its effectiveness in field trials [14].
Sulaiman et al. verified that 14.0 mg/L of triflumuron. Sul Maceió M. Claros Aracaju
larvae
Pupae
a,b b b c
aegypti Brazilian populations exposed to EI99. Populations are
ove columns indicate significant differences in pupae mortality
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simulated field conditions [41]. Likewise, Batra et al. found
that triflumuron was effective against Cx. quinquefasciatus
and Anopheles stephensi for seven weeks [42].
We also demonstrated that triflumuron is effective
against Ae. aegypti field populations exhibiting different
resistance levels to organophosphates and pyrethroids. In
such cases, a small number of larvae always remained alive
for many days, since the primary action of CSIs is not to
induce mortality, but to interfere with development.
Aedes aegypti larval mortality was more pronounced
when populations were treated with DD rather than
EI99, confirming the direct relationship between CSI
concentration and the precocity of its effects, likewise
this has previously been shown for the Rockefeller strain
[20]. However, total mortality occurred later in popula-
tions exposed to DD. Empirical observations during CSI
bioassays indicate that in many cases, a small number of
larvae remain alive for long periods, regardless of the
dosage. However, these larvae never progress to adult-
hood. Probably, this occurs due to natural variations
among specimens of field populations.
The absence of adult emergence when field popula-
tions are exposed to triflumuron, repudiates cross-
resistance between this CSI and neurotoxic inseticides.
However, a positive correlation between pupal mortality
rates and the temephos resistance ratios was noted,
suggesting a potential triflumuron tolerance in popula-
tions resistant to this OP. This triflumuron tolerance
could derive from the increased activity of enzymes
related to metabolic resistance, already detected in several
Brazilian Ae. aegypti populations [10,34]. In contrast,
correlation between deltamethrin mortality rates and
triflumuron induced pupae mortality in these Ae. aegypti
populations were not detected. This result may in part be
associated with the qualitative nature of the PY bioassay,
consisting of a single dose. Although there are few reports
concerning IGR resistance, diflubenzuron tolerance asso-
ciated with mixed-function oxidases was evidenced in
blowflies [43]. In mosquitoes however, to date IGR resist-
ance has not yet been directly associated with increased
activity of detoxifying enzymes.
Conclusions
Our results indicate that triflumuron was effective against
the three mosquito species evaluated. Furthermore, this
CSI was also potent against seven Ae. aegypti populations
resistant to the two major classes of insecticides currently
adopted in vector control. IGRs generally offer low toxicity
to mammals, including man. Therefore, triflumuron might
be considered an alternative for mosquito control in urban
areas, although it has not yet been approved for applica-
tion in drinking water, which precludes its use against
Ae. aegypti [44].Competing interests
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